250 related articles for article (PubMed ID: 14620515)
1. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.
Cisternino S; Rousselle C; Debray M; Scherrmann JM
Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515
[TBL] [Abstract][Full Text] [Related]
2. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
Cisternino S; Rousselle C; Debray M; Scherrmann JM
Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572
[TBL] [Abstract][Full Text] [Related]
3. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.
Cisternino S; Rousselle C; Dagenais C; Scherrmann JM
Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine.
Drion N; Lemaire M; Lefauconnier JM; Scherrmann JM
J Neurochem; 1996 Oct; 67(4):1688-93. PubMed ID: 8858954
[TBL] [Abstract][Full Text] [Related]
5. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
Declèves X; Chappey O; Boval B; Niel E; Scherrmann JM
Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid permeability across an in situ model of the blood-brain barrier.
Youdim KA; Qaiser MZ; Begley DJ; Rice-Evans CA; Abbott NJ
Free Radic Biol Med; 2004 Mar; 36(5):592-604. PubMed ID: 14980703
[TBL] [Abstract][Full Text] [Related]
8. Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line.
El Hafny B; Cano N; Piciotti M; Regina A; Scherrmann JM; Roux F
Biochem Pharmacol; 1997 Jun; 53(11):1735-42. PubMed ID: 9264327
[TBL] [Abstract][Full Text] [Related]
9. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
[TBL] [Abstract][Full Text] [Related]
10. Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.
Cisternino S; Rousselle C; Lorico A; Rappa G; Scherrmann JM
Pharm Res; 2003 Jun; 20(6):904-9. PubMed ID: 12817896
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.
Kusunoki N; Takara K; Tanigawara Y; Yamauchi A; Ueda K; Komada F; Ku Y; Kuroda Y; Saitoh Y; Okumura K
Jpn J Cancer Res; 1998 Nov; 89(11):1220-8. PubMed ID: 9914792
[TBL] [Abstract][Full Text] [Related]
12. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line.
El Hafny B; Chappey O; Piciotti M; Debray M; Boval B; Roux F
Neurosci Lett; 1997 Oct; 236(2):107-11. PubMed ID: 9404823
[TBL] [Abstract][Full Text] [Related]
13. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
[TBL] [Abstract][Full Text] [Related]
14. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method.
Moriki Y; Suzuki T; Fukami T; Hanano M; Tomono K; Watanabe J
Biol Pharm Bull; 2004 Jun; 27(6):932-5. PubMed ID: 15187451
[TBL] [Abstract][Full Text] [Related]
15. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
16. Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies.
Zhou Y; Zhou J; Li P; Xie Q; Sun B; Li Y; Chen Y; Zhao K; Yang T; Zhu L; Xu J; Liu X; Liu L
Eur J Pharmacol; 2019 Mar; 846():119-127. PubMed ID: 30639310
[TBL] [Abstract][Full Text] [Related]
17. Interaction of drugs with P-glycoprotein in brain capillaries.
Jetté L; Murphy GF; Leclerc JM; Beliveau R
Biochem Pharmacol; 1995 Nov; 50(10):1701-9. PubMed ID: 7503774
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells.
Letrent SP; Polli JW; Humphreys JE; Pollack GM; Brouwer KR; Brouwer KL
Biochem Pharmacol; 1999 Sep; 58(6):951-7. PubMed ID: 10509747
[TBL] [Abstract][Full Text] [Related]
19. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
